Day: January 12, 2022

Andy Polansky to Retire

Written by Customer Service on January 12, 2022. Posted in Public Companies.

Polansky Will Continue as IPG DXTRA CEO and Chairman and Weber Shandwick Executive Chairman through June 2022, Capping 38-Year Career as a Leader in Public Relations and Marketing Services New York, NY, Jan. 12, 2022 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) announced today that, following a prolific and successful career spanning nearly four decades, Andy Polansky, IPG DXTRA CEO and Weber Shandwick Executive Chairman, will retire in June of this year. Over the course of his long tenure within IPG, Polansky has held senior leadership positions at Weber Shandwick, including President and CEO, and more recently as Executive Chairman. Under his leadership, Weber Shandwick cemented its position as a global public relations powerhouse and one of the world’s largest and most awarded public relations firms. Polansky and the strong...

Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources

Written by Customer Service on January 12, 2022. Posted in Public Companies.

EWING, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, announced today the appointment of Claude E. Richardson as Senior Vice President of Human Resources. Mr. Richardson will be responsible for Antares’ corporate Human Resources (“HR”) strategy and development. Claude E. Richardson has more than 25 years of Human Resources leadership experience across multiple industries including pharmaceutical, industrials, financial services and consumer products. His broad-based background in Human Resources includes talent management and acquisition, compensation and benefits, development and training, performance management, organizational assessment, change management and HR strategy. Robert F. Apple, President and Chief Executive Officer of Antares Pharma,...

US Nuclear January 2022 Shareholder Letter

Written by Customer Service on January 12, 2022. Posted in Public Companies.

Los Angeles, CA, Jan. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — US Nuclear Corp. (OTCQB: UCLE): Dear US Nuclear Corporation Shareholders, Here we are. It is a new year and we wish all of you a safe, happy, and prosperous 2022. Unfortunately, the COVID pandemic is still affecting us all. Please stay well if you can. Our prayers go out to all those we have lost and their families. On to business: The COVID pandemic knocked down our revenue in 2020 due to shutdowns, restrictions, and precautions in response to the pandemic. The effects from the pandemic continued into 2021 due to supply chain and labor shortage problems. However, we are on our way back. 2020 Gross Revenue: $1,752,976 2021 Gross Revenue: $2,236,000*, up 27% from 2020 Looking forward, we are VERY optimistic: The number of RFQs we are bidding on...

Myovant Sciences to Host Third Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on January 26, 2022

Written by Customer Service on January 12, 2022. Posted in Public Companies.

BASEL, Switzerland, Jan. 12, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast and conference call to discuss corporate updates and financial results for its third fiscal quarter 2021, ended December 31, 2021. The webcast and conference call will be held at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time on January 26, 2022. Investors and the general public may access a live webcast of the call by visiting the investor relations page of Myovant’s website at investors.myovant.com. Institutional investors and analysts may also participate in the conference call by dialing 1-800-532-3746 in the U.S. or +1-470-495-9166 from outside the U.S. A replay of the webcast, along with the earnings press release and presentation...

PSYC’s Psychedelic Spotlight Nets 600K+ Page Views in December & Launches Revamped Site

Written by Customer Service on January 12, 2022. Posted in Public Companies.

LAKE OSWEGO, OR, Jan. 12, 2022 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging sector of medicinal psychedelics, and authorities behind Psychedelic Spotlight, a top ranking psychedelic news and information platform, is pleased to announce that its Psychedelic Spotlight media platform netted nearly 620K page views in the month of December 2021. This marks the third consecutive month in which the site realized more than half-a-million page views and further reinforced its evolution into a leading news and information hub for the medicinal psychedelic industry. In addition to the site’s impressive growth streak, the Company also completed the launch of a revamped version of its platform in late December. It’s intent, amongst other ongoing quality control...

Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility

Written by Customer Service on January 12, 2022. Posted in Public Companies.

BUFFALO, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that it has entered into a definitive agreement for ImmunityBio, Inc. (NASDAQ: IBRX) to assume its leasehold interest in a manufacturing facility in Dunkirk, New York, and certain related assets for approximately $38 million, subject to adjustment at closing. Proceeds from the sale will be used to service the Company’s debt obligations and for other general corporate purposes. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2022. Upon the closing, ImmunityBio will assume all capital expenditure and hiring obligations...

UniDoc Welcomes Strategic Technology Sales Advisor

Written by Customer Service on January 12, 2022. Posted in Public Companies.

Company advances multi-faceted solution-based approach to market differentiation VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, today welcomes the appointment of Mr. Lance Bailey to its Advisory Board. More information regarding the Company is available at www.unidoctor.com. As a telehealth provider, UniDoc is focussed on removing barriers to primary diagnostic assessment via enhanced physical accessibility through the reduction of technical obstacles to better assist underserved individuals and communities. As such, the Company is developing several innovative solutions that employ a user-friendly approach to packaging software-as-a-service (“SaaS”) systems and procedures in conjunction with purpose-built...

Paltalk Rolls Out New Content Moderation Software for Increased User Experience

Written by Customer Service on January 12, 2022. Posted in Public Companies.

Jericho, NY, Jan. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Paltalk, Inc. (NASDAQ: PALT) (“Paltalk,” the “Company,” “we,” “our” or “us”), a leading communications software innovator that powers multimedia social applications, is pleased to announce the integration of Hive Automated Content Moderation Solutions (“Hive”) into its Paltalk and Camfrog platforms. Paltalk is taking the next step to ensure a safe experience for its users by cracking down on spam and objectionable content. Hive uses powerful AI to detect offensive video, audio, and text through online content moderation. Through the Hive software, Paltalk will screen user-generated content in its video chat rooms. Paltalk will also leverage the text moderation feature of the Hive software platform to moderate its new “Paltalk Feed” feature to ensure it is being...

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

Written by Customer Service on January 12, 2022. Posted in Mergers And Acquisitions.

Six years remaining on lease for primary tenant at Winter Haven, Florida property ROCHESTER, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) — DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries, today announced its majority-owned subsidiary, American Medical REIT Inc. (“AMRE“), has acquired a tenanted 21,900 square foot medical office building in Winter Haven, Florida. Palm Medical Center (“Palm”), the primary tenant of the Winter Haven medical office building, leases nearly 19,000 sq. ft. of the property and has six years remaining on its lease with three five-year options to renew. Rent increases to Palm are limited to 1% annually, and Palm has a first right of refusal on any vacant space at the Winter Haven medical office building....

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update

Written by Customer Service on January 12, 2022. Posted in Earnings Releases And Operating Results.

Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022 $26.4 Million in Cash and Marketable Securities as of November 30, 2021 SOLANA BEACH, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today reported financial and operating results for the first quarter of its fiscal year ended November 30, 2021 and provided a business update. Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, said, “We continue our Cancer Appetite Recovery Study (CAReS), evaluating ART27.13 as a potential treatment for cancer-related anorexia. The results of Phase 1 will determine the safe and effective dose recommended...

Day: January 12, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals